A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 93.99
GOOG 682.40
MSFT 50.50
FB 102.01
BAC 11.95

Recently Added

OHI 28.18
UPS 97.25
LYB 76.46
FANG 69.13
CXO 87.15

Gaining Speed

OHI 28.18
UHS 104.26
CSU 14.68
MWA 8.13
BKD 11.80

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More

Get Alerted When News Hits On This Stock - FREE!